- Home
- TIXT vs NKTR Comparison
TIXT vs NKTR Comparison
Compare TIXT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- NKTR
- Stock Information
- Founded
- TIXT 2005
- NKTR 1990
- Country
- TIXT Canada
- NKTR United States
- Employees
- TIXT N/A
- NKTR N/A
- Industry
- TIXT EDP Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- NKTR Health Care
- Exchange
- TIXT Nasdaq
- NKTR Nasdaq
- Market Cap
- TIXT 1.3B
- NKTR 1.2B
- IPO Year
- TIXT 2021
- NKTR 1994
- Fundamental
- Price
- TIXT $4.49
- NKTR $56.89
- Analyst Decision
- TIXT Hold
- NKTR Strong Buy
- Analyst Count
- TIXT 6
- NKTR 6
- Target Price
- TIXT $3.90
- NKTR $91.67
- AVG Volume (30 Days)
- TIXT 527.3K
- NKTR 977.2K
- Earning Date
- TIXT 11-07-2025
- NKTR 11-06-2025
- Dividend Yield
- TIXT N/A
- NKTR N/A
- EPS Growth
- TIXT N/A
- NKTR N/A
- EPS
- TIXT N/A
- NKTR N/A
- Revenue
- TIXT $2,718,000,000.00
- NKTR $74,934,000.00
- Revenue This Year
- TIXT $5.34
- NKTR N/A
- Revenue Next Year
- TIXT $3.07
- NKTR N/A
- P/E Ratio
- TIXT N/A
- NKTR N/A
- Revenue Growth
- TIXT 2.03
- NKTR N/A
- 52 Week Low
- TIXT $2.13
- NKTR $6.48
- 52 Week High
- TIXT $4.60
- NKTR $62.95
- Technical
- Relative Strength Index (RSI)
- TIXT 65.08
- NKTR 58.87
- Support Level
- TIXT $4.47
- NKTR $52.91
- Resistance Level
- TIXT $4.52
- NKTR $62.82
- Average True Range (ATR)
- TIXT 0.01
- NKTR 3.35
- MACD
- TIXT -0.02
- NKTR -1.30
- Stochastic Oscillator
- TIXT 75.00
- NKTR 39.91
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.